Evidence map›Paper›PMID 36616170›Full record

ArticlePlants (Basel, Switzerland)2022

A New Benzothiadiazole Derivative with Systemic Acquired Resistance Activity in the Protection of Zucchini (

Maciej Spychalski, Rafal Kukawka, Raghavendra Prasad, Natasza Borodynko-Filas, Sylwia Stępniewska-Jarosz, Krzysztof Turczański, Marcin Smiglak

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maciej SpychalskiPoznan Science and Technology Park, Rubież 46, 61-612 Poznan, Poland.
Rafal KukawkaPoznan Science and Technology Park, Rubież 46, 61-612 Poznan, Poland.
Raghavendra PrasadEnvironmental Horticulture, Royal Horticultural Society (RHS), Wisley, Surrey GU23 6QB, UK.ORCID 0000-0003-0982-050X
Natasza Borodynko-FilasPlant Disease Clinic and Bank of Pathogens, Institute of Plant Protection-National Research Institute, ul. Węgorka 20, 60-318 Poznan, Poland.ORCID 0000-0002-4217-6421
Sylwia Stępniewska-JaroszPlant Disease Clinic and Bank of Pathogens, Institute of Plant Protection-National Research Institute, ul. Węgorka 20, 60-318 Poznan, Poland.ORCID 0000-0002-6259-4663
Krzysztof TurczańskiPoznan Science and Technology Park, Rubież 46, 61-612 Poznan, Poland.ORCID 0000-0002-8369-9165
Marcin SmiglakPoznan Science and Technology Park, Rubież 46, 61-612 Poznan, Poland.ORCID 0000-0003-4444-5354
Poznań University of Technology · PLInstitute of Plant Protection · PLRoyal Horticultural Society · GB

Funding

Foundation for Polish Science POIR.04/04.00-00-5BD9/17-00
6 · The paper itself

Abstract

The ability of plant resistance inducers to provide protection against viral diseases is one of their main advantages over conventional pesticides. In the case of viral diseases that cannot be controlled directly with pesticides, insecticides are used to control the vectors of viruses. However, the effectiveness of such treatments is strictly dependent on the time of application. The plant response to the application of systemic acquired resistance (SAR) inducers, as a result of the stimulating action of these substances, does not depend on the time of application as it triggers the plant's natural defence mechanism. The best-recognised substance showing SAR inducer activity is acibenzolar-S-methyl ester (ASM, BTH). As its activity against different plant pathogens of crops has been well documented, the current research is concentrated on the search for novel substances of the type. The tested substance,

Indexed as

benzothiadiazoleBTHWACABYVpowdery mildewsystemic acquired resistance (SAR)viral diseasesWMVZYMV

Identifiers

PMID36616170
PMCPMC9823545
OpenAlexW4312100582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.